01. History

History of the University of Hawaii Cancer Center

The University of Hawaii established its cancer center in 1981 on the island of Oahu in Hawaii’s capital city, Honolulu. It received its National Cancer Institute designation in 1996. This designation recognizes the center as one of the best cancer research institutions in the world and requires it to meet stringent requirements and undergo constant evaluation.

The University of Hawaii Cancer Center focuses strongly on cancer research in an effort to find better treatment techniques and diagnostic tools. As of 2018, this cancer is one of a mere 70 research institutes to receive designation from the National Cancer Institute. Researchers at the University of Hawaii Cancer Center work in three interdisciplinary programs: epidemiology (a science that deals with the distribution and control of diseases), cancer biology and cancer prevention and control. Within those programs, they conduct cutting-edge research in areas like epidemiology, molecular carcinogenesis, cancer treatment and prevention methodology. An important aspect of the cancer center’s work is outreach to Hawaii’s multiethnic community, including education, particularly about prevention, and support programs for cancer survivors.

02. Mesothelioma Care

Mesothelioma Care at the University of Hawaii Cancer Center

The University of Hawaii Cancer Center is a global leader in mesothelioma research. Under the leadership of center director Michele Carbone, a pathologist who specializes in mesothelioma, researchers at the center have made important discoveries about the disease. They have identified the gene that causes mesothelioma, BAP1, and a protein that is critical in the development of the disease, which has led to many studies internationally to better understand the connection.

The University of Hawaii Cancer Center continues its research throughclinical trials. Clinical trials allow eligible mesothelioma patients to try emerging treatments that have not yet become available to everyone. The cancer center acknowledges that cancers like malignant mesothelioma can be very aggressive.Standard mesothelioma treatment optionsmay not be the best option for all patients.

03. Specializations

夏威夷大学癌症Center Specializations

• Cancer research
• Clinical trials

04. Accreditations

夏威夷大学癌症Center Accreditations

• National Cancer Institute Designated Cancer Center
• National Cancer Institute Community Oncology Research Program designation

Have a Question About This Cancer Center?

Ask experienced mesothelioma advocate Jennifer Lucarelli

Ask a Question

05. Mesothelioma Clinical Trials

Mesothelioma Clinical Trials at the University of Hawaii Cancer Center

The following clinical trials are in progress or actively recruiting participants at the University of Hawaii Cancer Center:

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

---

Conditions:Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Adenocarcinoma of Lung, Teratoma, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Cystadenocarcinoma, Serous, Choriocarcinoma, Carcinoma, Endometrioid, Cystadenocarcinoma, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Nerve Sheath Neoplasms, Gestational Trophoblastic Disease, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Carcinoma, Acinar Cell, Adenocarcinoma, Papillary, Adenocarcinoma, Bronchiolo-Alveolar, Neoplasms, Unknown Primary, Mixed Tumor, Mullerian, Adenocarcinoma, Clear Cell, Carcinoma, Giant Cell

Last Updated:December 1, 2021

Status:Recruiting

Show All Clinical Trials